share_log

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SOKOLOW LEONARD J

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SOKOLOW LEONARD J

Vivos Therapeutics | 4：持股變動聲明-董事 SOKOLOW LEONARD J
美股SEC公告 ·  06/29 08:57
牛牛AI助理已提取核心訊息
In a recent transaction, Leonard J Sokolow engaged in the sale of shares from Vivos Therapeutics, Inc. (VVOS). The transaction took place on June 20, 2024. However, the specific details regarding the number of shares sold, the transaction price, and the resulting ownership stake after the sale were not disclosed in the announcement. This information is critical for investors to assess the impact of the transaction on their investment decisions.
In a recent transaction, Leonard J Sokolow engaged in the sale of shares from Vivos Therapeutics, Inc. (VVOS). The transaction took place on June 20, 2024. However, the specific details regarding the number of shares sold, the transaction price, and the resulting ownership stake after the sale were not disclosed in the announcement. This information is critical for investors to assess the impact of the transaction on their investment decisions.
最近，Leonard J Sokolow從Vivos Therapeutics，Inc. (VVOS)出售了股票。該交易發生在2024年6月20日。然而，在宣佈中沒有披露有關出售股票的數量、交易價格以及出售後的持股比例的具體細節。這些信息對於投資者評估交易對其投資決策的影響至關重要。
最近，Leonard J Sokolow從Vivos Therapeutics，Inc. (VVOS)出售了股票。該交易發生在2024年6月20日。然而，在宣佈中沒有披露有關出售股票的數量、交易價格以及出售後的持股比例的具體細節。這些信息對於投資者評估交易對其投資決策的影響至關重要。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。